Concepedia

Robbert Boudewijns

RB

21

Publications

1.6K

Citations

17

H-Index

2018

Active since

Affiliations

KU Leuven(Current)

Rega Institute for Medical Research

Global Virus Network

Ghent University

VIB-UGent Center for Medical Biotechnology

Robbert Boudewijns is an author at KU Leuven specializing in medicine, covid-19, and immunology.

ORCID

Top concepts

Publications per year

2018–2022

21

Publications

21

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters

Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J. F. Kaptein et al. · Nature Communications · 2020 · 287 citations · Full text

Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity

Suzanne J. F. Kaptein, Sofie Jacobs, Lana Langendries et al. · Proceedings of the National Academy of Sciences · 2020 · 281 citations · Full text

, , +14

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

Lorena Sánchez-Felipe, Thomas Vercruysse, Sapna Sharma et al. · Nature · 2020 · 184 citations · Full text

Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines

Nicholas Hernandez, Giorgia Bucciol, Leen Moens et al. · The Journal of Experimental Medicine · 2019 · 172 citations · Full text

Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters

Rana Abdelnabi, Robbert Boudewijns, Caroline S. Foo et al. · EBioMedicine · 2021 · 137 citations · Full text

Rows per page

1–5 of 21